MEK (MAPKK) inhibitors. Part 2: structure–activity relationships of 4-anilino-3-cyano-6,7-dialkoxyquinolines
- 25 May 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (11) , 1407-1410
- https://doi.org/10.1016/s0960-894x(01)00238-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Organization and regulation of mitogen-activated protein kinase signaling pathwaysPublished by Elsevier ,1999
- Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous MessengersMolecular and Cellular Biology, 1999
- Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosisOncogene, 1997
- Activation of Raf-1 in Human Pancreatic AdenocarcinomaJournal of Surgical Research, 1997
- Hyperexpression of mitogen-activated protein kinase in human breast cancer.Journal of Clinical Investigation, 1997
- How MAP Kinases Are RegulatedJournal of Biological Chemistry, 1995
- The MAPK signaling cascadeThe FASEB Journal, 1995
- Raf-1 protein expression in human breast cancer cellsAnnals of Surgical Oncology, 1995
- The v-raf oncogene enhances tumorigenicity and suppresses differentiation in vivo in a rat hepatocyte cell lineCarcinogenesis: Integrative Cancer Research, 1993
- Transformation of a mammary epithelial cell line by the v-raf and v-mos oncogenesInternational Journal of Cancer, 1991